News
Japanese drugmaker Shionogi said on Wednesday that it will acquire Torii Pharmaceutical , a subsidiary of Japan Tobacco , for ...
Japan Tobacco Inc. ( OTCPK:JAPAY) Q1 2025 Results Conference Call May 7, 2025 6:00 AM ET Hiromasa Furukawa - Group Chief Financial Officer Dinesh Babu Thotakura - General Manager Nobuya Kato - JTI ...
Shionogi has reached a JPY 151 billion ($1.04 billion) agreement to buy the pharmaceutical subsidiary of Japan Tobacco, Torii ...
Bain Capital bought Mitsubishi Tanabe Pharma for $3.5 billion while Blackstone acquired a majority stake in one of Japan’s ...
OSAKA/TOKYO -- Japanese drugmaker Shionogi said Wednesday that it will acquire Torii Pharmaceutical and other assets from Japan Tobacco in a deal worth around 160 billion yen ($1.1 billion), ...
Shionogi & Co. said it plans to acquire Japan Tobacco Inc. (JT) subsidiaries Torii Pharmaceutical Co. and Akros Pharma Inc. for ¥160 billion (US$1.1 billion) to expand its global R&D business. The two ...
This article was published by IBN, a multifaceted communications organization engaged in connecting public companies to the ...
(RTTNews) - Japan Tobacco Inc. (JAPAF.PK, JAPAY.PK) on Wednesday posted higher profit in its first quarter, helped by higher revenues. The company also provided outlook for the year ahead.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results